LONA LeonaBio, Inc.
Nasdaq · SEC CIK 1620463 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $99.4K 10 sales by 5 insiders
- Filings on record
- 160 since 2021-07-21, latest 2026-07-10 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Litton Mark James | Pres, CEO, Dir | — | $45.5K |
| San Martin Javier | Chief MEDICAL Off | — | $20.5K |
| CHURCH KEVIN | CSO | — | $13.3K |
| Worthington Mark | GC, CCO | — | $13.2K |
| Renninger Robert | CFO | — | $6,909 |
| PERCEPTIVE ADVISORS LLC | Dir, 10% | — | — |
Transactions 123
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | LONA | Litton Mark James | Pres, CEO, Dir | M - OptEx | $0.00 | +22.3K | 63.1K | +55% | $0 |
| D | 2026-03-05 | 2026-03-04 | LONA | Litton Mark James | Pres, CEO, Dir | S - Sale+OE | $5.37 | -5,156 | 57.9K | -8% | -$27.7K |
| D | 2026-03-05 | 2026-03-03 | LONA | San Martin Javier | Chief MEDICAL Off | M - OptEx | $0.00 | +7,418 | 17.6K | +73% | $0 |
| D | 2026-03-05 | 2026-03-04 | LONA | San Martin Javier | Chief MEDICAL Off | S - Sale+OE | $5.37 | -1,720 | 15.9K | -10% | -$9,236 |
| D | 2026-03-05 | 2026-03-03 | LONA | Worthington Mark | GC, CCO | M - OptEx | $0.00 | +5,726 | 19.7K | +41% | $0 |
| D | 2026-03-05 | 2026-03-04 | LONA | Worthington Mark | GC, CCO | S - Sale+OE | $5.37 | -1,328 | 18.4K | -7% | -$7,131 |
| D | 2026-03-05 | 2026-03-04 | LONA | CHURCH KEVIN | CSO | S - Sale+OE | $5.37 | -1,359 | 25.2K | -5% | -$7,298 |
| D | 2026-03-05 | 2026-03-03 | LONA | CHURCH KEVIN | CSO | M - OptEx | $0.00 | +5,856 | 26.5K | +28% | $0 |
| D | 2026-03-05 | 2026-03-04 | LONA | Renninger Robert | CFO | S - Sale+OE | $5.37 | -906 | 15.9K | -5% | -$4,865 |
| D | 2026-03-05 | 2026-03-03 | LONA | Renninger Robert | CFO | M - OptEx | $0.00 | +3,900 | 16.8K | +30% | $0 |
| D | 2026-01-05 | 2025-12-31 | LONA | Renninger Robert | CFO | M - OptEx | $0.00 | +1,236 | 13.2K | +10% | $0 |
| D | 2026-01-05 | 2025-11-18 | LONA | Renninger Robert | CFO | A - Grant | $2.31 | +1,000 | 11.9K | +9% | +$2,310 |
| D | 2026-01-05 | 2026-01-02 | LONA | Renninger Robert | CFO | S - Sale+OE | $6.88 | -297 | 12.9K | -2% | -$2,043 |
| D | 2026-01-05 | 2026-01-02 | LONA | Litton Mark James | Pres, CEO, Dir | S - Sale+OE | $6.88 | -2,586 | 40.8K | -6% | -$17.8K |
| D | 2026-01-05 | 2025-12-31 | LONA | Litton Mark James | Pres, CEO, Dir | M - OptEx | $0.00 | +10.8K | 43.4K | +33% | $0 |
| D | 2026-01-05 | 2026-01-02 | LONA | CHURCH KEVIN | CSO | S - Sale+OE | $6.88 | -876 | 20.7K | -4% | -$6,027 |
| D | 2026-01-05 | 2025-11-18 | LONA | CHURCH KEVIN | CSO | A - Grant | $2.31 | +1,000 | 17.9K | +6% | +$2,310 |
| D | 2026-01-05 | 2025-12-31 | LONA | CHURCH KEVIN | CSO | M - OptEx | $0.00 | +3,667 | 21.6K | +20% | $0 |
| D | 2026-01-05 | 2026-01-02 | LONA | Worthington Mark | GC, CCO | S - Sale+OE | $6.88 | -876 | 14.0K | -6% | -$6,027 |
| D | 2026-01-05 | 2025-12-31 | LONA | Worthington Mark | GC, CCO | M - OptEx | $0.00 | +3,667 | 14.9K | +33% | $0 |
| D | 2026-01-05 | 2026-01-02 | LONA | San Martin Javier | Chief MEDICAL Off | S - Sale+OE | $6.88 | -1,644 | 10.2K | -14% | -$11.3K |
| D | 2026-01-05 | 2025-12-31 | LONA | San Martin Javier | Chief MEDICAL Off | M - OptEx | $0.00 | +4,667 | 11.8K | +65% | $0 |
| DMI | 2025-12-23 | 2025-12-23 | LONA | PERCEPTIVE ADVISORS LLC | Dir, 10% | A - Grant | $6.35 | +1.32M | 329.8K | New | +$8.38M |
| D | 2025-07-02 | 2025-07-01 | LONA | Renninger Robert | SVP, Fin, Accounting | S - Sale+OE | $0.29 | -2,897 | 109.2K | -3% | -$840.13 |
| D | 2025-07-02 | 2025-05-19 | LONA | Renninger Robert | SVP, Fin, Accounting | A - Grant | $0.23 | +10.0K | 99.7K | +11% | +$2,300 |
| D | 2025-07-02 | 2025-06-30 | LONA | Renninger Robert | SVP, Fin, Accounting | M - OptEx | $0.00 | +12.4K | 112.1K | +12% | $0 |
| D | 2025-07-02 | 2025-07-01 | LONA | CHURCH KEVIN | CSO | S - Sale+OE | $0.29 | -8,526 | 168.9K | -5% | -$2,473 |
| D | 2025-07-02 | 2025-05-19 | LONA | CHURCH KEVIN | CSO | A - Grant | $0.23 | +10.0K | 140.8K | +8% | +$2,300 |
| D | 2025-07-02 | 2025-06-30 | LONA | CHURCH KEVIN | CSO | M - OptEx | $0.00 | +36.7K | 177.4K | +26% | $0 |
| D | 2025-07-02 | 2025-06-30 | LONA | Worthington Mark | GC, CCO | M - OptEx | $0.00 | +36.7K | 120.4K | +44% | $0 |
| D | 2025-07-02 | 2025-07-01 | LONA | Worthington Mark | GC, CCO | S - Sale+OE | $0.29 | -8,526 | 111.9K | -7% | -$2,473 |
| D | 2025-07-02 | 2025-07-01 | LONA | Litton Mark James | Pres, CEO, Dir | S - Sale+OE | $0.29 | -25.1K | 325.8K | -7% | -$7,286 |
| D | 2025-07-02 | 2025-06-30 | LONA | Litton Mark James | Pres, CEO, Dir | M - OptEx | $0.00 | +108.3K | 350.9K | +45% | $0 |
| D | 2025-07-02 | 2025-06-30 | LONA | San Martin Javier | Chief MEDICAL Off | M - OptEx | $0.00 | +46.7K | 82.5K | +130% | $0 |
| D | 2025-07-02 | 2025-07-01 | LONA | San Martin Javier | Chief MEDICAL Off | S - Sale+OE | $0.29 | -10.8K | 71.7K | -13% | -$3,144 |
| D | 2025-01-03 | 2025-01-02 | LONA | Worthington Mark | GC, CCO | S - Sale+OE | $0.56 | -8,510 | 83.7K | -9% | -$4,766 |
| D | 2025-01-03 | 2024-12-31 | LONA | Worthington Mark | GC, CCO | M - OptEx | $0.00 | +36.7K | 92.2K | +66% | $0 |
| D | 2025-01-03 | 2024-11-18 | LONA | Worthington Mark | GC, CCO | A - Grant | $0.55 | +3,651 | 55.6K | +7% | +$2,008 |
| D | 2025-01-03 | 2025-01-02 | LONA | Litton Mark James | Pres, CEO, Dir | S - Sale+OE | $0.56 | -25.1K | 242.6K | -9% | -$14.1K |
| D | 2025-01-03 | 2024-12-31 | LONA | Litton Mark James | Pres, CEO, Dir | M - OptEx | $0.00 | +108.3K | 267.7K | +68% | $0 |
| D | 2025-01-03 | 2024-11-18 | LONA | Renninger Robert | VP of Fin | A - Grant | $0.55 | +3,651 | 80.2K | +5% | +$2,008 |
| D | 2025-01-03 | 2024-12-31 | LONA | Renninger Robert | VP of Fin | M - OptEx | $0.00 | +12.4K | 92.6K | +15% | $0 |
| D | 2025-01-03 | 2025-01-02 | LONA | Renninger Robert | VP of Fin | S - Sale+OE | $0.56 | -2,881 | 89.7K | -3% | -$1,613 |
| D | 2025-01-03 | 2025-01-02 | LONA | CHURCH KEVIN | CSO | S - Sale+OE | $0.56 | -8,510 | 130.8K | -6% | -$4,766 |
| D | 2025-01-03 | 2024-11-18 | LONA | CHURCH KEVIN | CSO | A - Grant | $0.55 | +9,920 | 102.6K | +11% | +$5,456 |
| D | 2025-01-03 | 2024-12-31 | LONA | CHURCH KEVIN | CSO | M - OptEx | $0.00 | +36.7K | 139.3K | +36% | $0 |
| D | 2025-01-03 | 2025-01-02 | LONA | San Martin Javier | Chief MEDICAL Off | S - Sale+OE | $0.56 | -10.8K | 35.8K | -23% | -$6,063 |
| D | 2025-01-03 | 2024-12-31 | LONA | San Martin Javier | Chief MEDICAL Off | M - OptEx | $0.00 | +46.7K | 46.7K | New | $0 |
| M | 2024-09-05 | 2024-05-20+ | LONA | Gengos Andrew | CFO, Chief Business Off | A - Grant | $0.8933 | +15.0K | 98.8K | +18% | +$13.4K |
| 2024-09-05 | 2024-09-05 | LONA | Gengos Andrew | CFO, Chief Business Off | S - Sale | $0.57 | -1,272 | 97.5K | -1% | -$725.04 | |
| 2024-09-05 | 2024-09-05 | LONA | Litton Mark James | Pres, CEO, Dir | S - Sale | $0.57 | -5,032 | 159.4K | -3% | -$2,868 | |
| 2024-09-05 | 2024-09-03 | LONA | Litton Mark James | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 164.4K | +14% | $0 | |
| 2024-09-05 | 2024-09-05 | LONA | Lenington Rachel | COO, CDO | S - Sale | $0.57 | -2,525 | 20.9K | -11% | -$1,439 | |
| 2024-09-05 | 2024-09-03 | LONA | Lenington Rachel | COO, CDO | A - Grant | $0.00 | +10.0K | 23.4K | +75% | $0 | |
| M | 2024-09-05 | 2024-05-20+ | LONA | CHURCH KEVIN | CSO | A - Grant | $0.4439 | +15.0K | 95.2K | +19% | +$6,637 |
| 2024-09-05 | 2024-09-05 | LONA | CHURCH KEVIN | CSO | S - Sale | $0.57 | -2,525 | 92.7K | -3% | -$1,439 | |
| 2024-09-05 | 2024-09-05 | LONA | Worthington Mark | GC | S - Sale | $0.57 | -2,525 | 51.9K | -5% | -$1,439 | |
| M | 2024-09-05 | 2024-05-20+ | LONA | Worthington Mark | GC | A - Grant | $0.67 | +20.0K | 54.5K | +58% | +$13.4K |
| M | 2024-06-25 | 2024-06-21+ | LONA | Romano Kelly A | Dir | P - Purchase | $2.36 | +42.4K | 80.7K | +111% | +$100.2K |
| A | 2024-02-16 | 2024-01-05 | LONA | Litton Mark James | CEO, Dir | S - Sale | $2.91 | -4,820 | 144.4K | -3% | -$14.0K |
| A | 2024-02-16 | 2024-01-04 | LONA | Litton Mark James | CEO, Dir | A - Grant | $0.00 | +20.0K | 149.2K | +15% | $0 |
| MA | 2024-02-16 | 2023-05-18+ | LONA | Worthington Mark | GC | A - Grant | $1.05 | +17.8K | 26.9K | +195% | +$18.7K |
| A | 2024-02-16 | 2024-01-05 | LONA | Worthington Mark | GC | S - Sale | $2.91 | -2,412 | 34.5K | -7% | -$7,019 |
| A | 2024-02-16 | 2024-01-04 | LONA | Gengos Andrew | CFO AND Chief BUSINESS Off | A - Grant | $0.00 | +5,000 | 85.0K | +6% | $0 |
| A | 2024-02-16 | 2024-01-05 | LONA | Gengos Andrew | CFO AND Chief BUSINESS Off | S - Sale | $2.91 | -1,208 | 83.8K | -1% | -$3,515 |
| A | 2024-02-16 | 2024-01-05 | LONA | CHURCH KEVIN | CSO | S - Sale | $2.91 | -2,412 | 80.3K | -3% | -$7,019 |
| MA | 2024-02-16 | 2023-05-18+ | LONA | CHURCH KEVIN | CSO | A - Grant | $0.4577 | +14.2K | 82.7K | +21% | +$6,502 |
| A | 2024-02-16 | 2024-01-04 | LONA | Lenington Rachel | COO AND CDO | A - Grant | $0.00 | +10.0K | 15.8K | +172% | $0 |
| A | 2024-02-16 | 2024-01-05 | LONA | Lenington Rachel | COO AND CDO | S - Sale | $2.91 | -2,412 | 13.4K | -15% | -$7,019 |
| 2024-01-08 | 2023-01-05 | LONA | Gengos Andrew | See Below | S - Sale | $2.91 | -1,208 | 83.8K | -1% | -$3,515 | |
| 2024-01-08 | 2023-01-04 | LONA | Gengos Andrew | See Below | A - Grant | $0.00 | +5,000 | 85.0K | +6% | $0 | |
| M | 2024-01-08 | 2023-01-04+ | LONA | CHURCH KEVIN | CSO | A - Grant | $0.4577 | +14.2K | 72.7K | +24% | +$6,502 |
| 2024-01-08 | 2023-01-05 | LONA | CHURCH KEVIN | CSO | S - Sale | $2.91 | -2,412 | 80.3K | -3% | -$7,019 | |
| 2024-01-08 | 2024-01-05 | LONA | Lenington Rachel | COO | S - Sale | $2.91 | -2,412 | 13.4K | -15% | -$7,019 | |
| 2024-01-08 | 2024-01-04 | LONA | Lenington Rachel | COO | A - Grant | $0.00 | +10.0K | 15.8K | +172% | $0 | |
| 2024-01-08 | 2024-01-04 | LONA | MOEBIUS HANS | Chief Medical Off | A - Grant | $0.00 | +10.0K | 91.5K | +12% | $0 | |
| M | 2024-01-08 | 2023-05-18+ | LONA | Worthington Mark | GC | A - Grant | $1.05 | +17.8K | 36.9K | +93% | +$18.7K |
| 2024-01-08 | 2024-01-05 | LONA | Worthington Mark | GC | S - Sale | $2.91 | -2,412 | 34.5K | -7% | -$7,019 | |
| 2024-01-08 | 2024-01-04 | LONA | Litton Mark James | CEO, Dir | A - Grant | $0.00 | +20.0K | 149.2K | +15% | $0 | |
| 2024-01-08 | 2024-01-05 | LONA | Litton Mark James | CEO, Dir | S - Sale | $2.91 | -4,820 | 144.4K | -3% | -$14.0K | |
| MI | 2023-12-29 | 2023-12-27+ | LONA | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $2.42 | +605.7K | 5.24M | +13% | +$1.46M |
| M | 2023-06-09 | 2023-06-07 | LONA | Gengos Andrew | See Below | P - Purchase | $3.43 | +15.0K | 68.3K | +28% | +$51.5K |
| M | 2023-06-06 | 2023-06-02+ | LONA | Gengos Andrew | See Below | P - Purchase | $2.95 | +65.0K | 35.0K | New | +$191.6K |
| D | 2023-06-06 | 2023-06-02 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $1.35 | +7,882 | 81.5K | +11% | +$10.6K |
| D | 2023-06-06 | 2023-05-18 | LONA | MOEBIUS HANS | Chief Medical Off | A - Grant | $2.41 | +7,764 | 73.6K | +12% | +$18.7K |
| M | 2023-03-31 | 2023-03-29+ | LONA | PICKERING GRANT | Dir | P - Purchase | $2.41 | +25.0K | 25.8K | +3,193% | +$60.4K |
| 2023-03-30 | 2023-03-29 | LONA | JOHNSON JAMES A | Dir | P - Purchase | $2.40 | +5,000 | 5,000 | New | +$12.0K | |
| D | 2023-03-27 | 2023-03-24 | LONA | CHURCH KEVIN | CSO | M - OptEx | $1.35 | +6,410 | 68.5K | +10% | +$8,654 |
| D | 2023-01-31 | 2022-11-18 | LONA | Litton Mark James | CEO, Dir | A - Grant | $2.74 | +662 | 129.2K | +0.5% | +$1,814 |
| D | 2023-01-23 | 2022-11-18 | LONA | CHURCH KEVIN | Executive VP, Research | A - Grant | $2.74 | +657 | 62.1K | +1% | +$1,800 |
| 2022-12-30 | 2022-11-18 | LONA | MILESON GLENNA | CFO | A - Grant | $2.74 | +763 | 109.9K | +0.7% | +$2,091 | |
| 2022-12-30 | 2022-12-28 | LONA | MILESON GLENNA | CFO | P - Purchase | $2.85 | +50.0K | 159.9K | +45% | +$142.5K | |
| 2022-12-06 | 2022-12-02 | LONA | Romano Kelly A | Dir | P - Purchase | $3.29 | +30.0K | 38.3K | +361% | +$98.7K | |
| 2022-11-17 | 2022-11-15 | LONA | MOEBIUS HANS | Chief Medical Off | P - Purchase | $3.29 | +5,000 | 65.8K | +8% | +$16.4K | |
| D | 2022-10-31 | 2022-10-28 | LONA | CHURCH KEVIN | Executive VP, Research | M - OptEx | $1.35 | +3,700 | 61.4K | +6% | +$4,995 |
| D | 2022-10-17 | 2022-10-13 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $1.35 | +7,881 | 60.8K | +15% | +$10.6K |
| MI | 2022-07-01 | 2022-06-29+ | LONA | EDELMAN JOSEPH | Dir, 10% | P - Purchase | $2.99 | +1.37M | 4.80M | +40% | +$4.10M |
| 2022-06-30 | 2022-06-28 | LONA | MOEBIUS HANS | Chief Medical Off | P - Purchase | $2.88 | +10.0K | 53.0K | +23% | +$28.8K | |
| M | 2022-06-24 | 2022-05-18+ | LONA | Worthington Mark | GC | A - Grant | $1.79 | +13.4K | 11.7K | New | +$24.0K |
| 2022-06-24 | 2022-06-23 | LONA | Worthington Mark | GC | S - Sale | $2.69 | -2,614 | 19.1K | -12% | -$7,032 |
Purchase Sale Sale after option exercise All abbreviations